The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and DesignDerek C. Angus, Steven Webb, Kristine Broglio et al.|Annals of the American Thoracic Society|2020Cited by 449
Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocolYaseen M. Arabi, Robert Fowler, Hanan H. Balkhy et al.|SpringerPlus|2015Cited by 206
The relevance of respiratory viral infections in the exacerbations of chronic obstructive pulmonary disease—A systematic reviewW A R Zwaans, Gernot Rohde, Patrick Mallia et al.|Journal of Clinical Virology|2014Cited by 131
Open source clinical science for emerging infectionsJake Dunning, J. Kenneth Baillie, Laura Merson et al.|The Lancet Infectious Diseases|2013Cited by 98